Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats
about
Is lipid signaling through cannabinoid 2 receptors part of a protective system?Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseasesMain ion channels and receptors associated with visceral hypersensitivity in irritable bowel syndromeInhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in miceRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationPharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.CB2: a cannabinoid receptor with an identity crisisDifferential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice.Membrane TLR signaling mechanisms in the gastrointestinal tract during sepsis.Cannabinoids alleviate experimentally induced intestinal inflammation by acting at central and peripheral receptors.Role of principal ionotropic and metabotropic receptors in visceral pain.Endocannabinoid signaling at the periphery: 50 years after THC.Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice.Recent advances in small bowel diseases: Part II.Evidence for the putative cannabinoid receptor (GPR55)-mediated inhibitory effects on intestinal contractility in mice.A potential role for GPR55 in gastrointestinal functionsModulating the endocannabinoid system in human health and disease--successes and failuresInhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat.Emerging strategies for exploiting cannabinoid receptor agonists as medicines.Modulation of motor and sensory pathways of the peristaltic reflex by cannabinoids.Involvement of Cannabinoid Signaling in Vincristine-Induced Gastrointestinal Dysmotility in the Rat.Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies.Cannabinoid Receptors in Regulating the GI Tract: Experimental Evidence and Therapeutic Relevance.Endocannabinoids in the gastrointestinal tract.The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease.Cannabinoids and GI Disorders: Endogenous and Exogenous.Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting.Lipopolysaccharides facilitate colonic motor alterations associated to the sensitization to a luminal antigen in rats.Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling.Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis.Roles of Toll-Like Receptor 4, IκB Kinase, and the Proteasome in the Intestinal Alterations Caused by Sepsis.Primary cilia modulate TLR4-mediated inflammatory responses in hippocampal neuronsCannabinoids mediate opposing effects on inflammation-induced intestinal permeability.Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice.Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity.Anti-inflammatory cannabinoids in diet: Towards a better understanding of CB(2) receptor action?Differential effects of salvinorin A on endotoxin-induced hypermotility and neurogenic ion transport in mouse ileum.Proinflammatory stimuli activates human-derived enteroglial cells and induces autocrine nitric oxide production.Salvinorin A inhibits colonic transit and neurogenic ion transport in mice by activating kappa-opioid and cannabinoid receptors.
P2860
Q24633122-02649924-7363-4250-A887-7035E9DCA60CQ26824588-362F687E-2284-4AF6-8A70-0A5AD09A77E1Q26862565-C1C5D1AD-2DE5-4CE3-A443-4511FA7762DAQ28258759-A5404EEF-6566-43B6-9DD7-211D4C6B3712Q30357558-D82281B0-18C7-44D7-80F7-347A2172F3B7Q34078746-4C42ACC7-149B-4A81-84CA-9185017690F5Q34098185-57B14AD5-85CF-4145-8D7F-F5659407F788Q34145142-AE2160FA-FF28-4EFB-BE2E-E9D75AE5A10CQ34180620-BBE00F71-2050-4980-B495-9989D1D3691EQ35294138-2EFA6F1E-5F71-4F05-B19B-9651CC13454DQ35430526-3272A2F0-7472-4CD9-BD09-13F6FB6CA840Q35572176-CFA25F80-1E4D-4505-8758-42CA57AF5542Q36024979-983B38B8-9F25-46FE-BF62-549D8A771EADQ36093336-F4F06F71-E8F5-4C45-B778-543D72697421Q36544859-9527D0CA-38CE-49DC-B378-DC43253FDE36Q36864469-A5BD1055-C621-48A8-BA2C-D5BD10695E86Q36933683-51C725CF-46EC-4406-AEF5-4CF9B8BC8EC0Q36977483-754B504E-CC70-47AA-ABF9-AFB8A3FF12E5Q37032490-9B2FF323-DB4A-482B-B02B-2B654E54515AQ37230665-9FB7B774-64AC-44A8-B79C-56CD8DE2AA59Q37337693-3982F275-0252-46F2-8756-FDDF98D50B53Q37625445-538FBDC9-32A8-404A-BFE0-8C3644B6E17CQ37960078-36F3A23E-4D90-4D2E-BD9A-143D7660CC84Q38761437-081B105F-4B92-49A3-8339-D05526D36368Q38931168-0C48FBDA-F9DB-409E-AFFD-260B5E141ED1Q38937293-B4A183E4-C59D-4FD1-AEEB-24656D3F6D83Q38971616-20BEB12D-0990-4B5D-832F-1BC4A87398C2Q38974456-DBA857CC-7298-40FF-86F4-DA1981EB02C2Q39665407-A5A28476-4581-44D0-AC86-62B54BA7F401Q40997924-6AB3F10F-C504-4DDF-8CFE-CBF454E88BA6Q41155333-66EF6F61-B58C-4F84-9C11-3AE744C73864Q41676849-3A462D6D-7A1D-43A7-927F-1F7E75128C83Q41714802-05AFC6FE-972D-4081-BBA9-B84E7D0C00DBQ41963239-715CBC68-74C7-4B23-9B66-EDCB991996E6Q42730246-03844C4B-1CCE-442A-BAC2-2EFCA10AD41EQ43019372-6C1EFFCE-2889-4467-9EB8-24663419A129Q43190361-58BDD443-8528-4B4C-BA66-13E9C5F99A4FQ43327487-9A72FAE8-1968-421D-9D1A-97610E61897AQ44201488-8F73903F-AC56-4EBE-875F-E7FD89AB846EQ44343638-48A5A749-5ECF-40B7-A1DE-FDACFE3E496F
P2860
Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats
description
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2008
@ast
scientific journal article
@en
vedecký článok (publikovaný 2008/07/01)
@sk
vědecký článek publikovaný v roce 2008
@cs
wetenschappelijk artikel (gepubliceerd op 2008/07/01)
@nl
наукова стаття, опублікована в липні 2008
@uk
مقالة علمية (نشرت في يوليو 2008)
@ar
name
Cannabinoid CB2 receptors in t ...... ipopolysaccharide-treated rats
@ast
Cannabinoid CB2 receptors in t ...... ipopolysaccharide-treated rats
@en
Cannabinoid CB2 receptors in t ...... ipopolysaccharide-treated rats
@nl
type
label
Cannabinoid CB2 receptors in t ...... ipopolysaccharide-treated rats
@ast
Cannabinoid CB2 receptors in t ...... ipopolysaccharide-treated rats
@en
Cannabinoid CB2 receptors in t ...... ipopolysaccharide-treated rats
@nl
prefLabel
Cannabinoid CB2 receptors in t ...... ipopolysaccharide-treated rats
@ast
Cannabinoid CB2 receptors in t ...... ipopolysaccharide-treated rats
@en
Cannabinoid CB2 receptors in t ...... ipopolysaccharide-treated rats
@nl
P2093
P2860
P50
P921
P356
P1476
Cannabinoid CB2 receptors in t ...... ipopolysaccharide-treated rats
@en
P2093
Abdeslam Mouihate
Catherine M Keenan
Joseph S Davison
Kamala D Patel
Marnie Duncan
Nancy E Buckley
P2860
P304
P356
10.1152/AJPGI.90285.2008
P577
2008-05-15T00:00:00Z